Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 17:14:3207-3218.
doi: 10.2147/IDR.S291511. eCollection 2021.

Understanding Factors in Group B Streptococcus Late-Onset Disease

Affiliations
Review

Understanding Factors in Group B Streptococcus Late-Onset Disease

Alberto Berardi et al. Infect Drug Resist. .

Abstract

Group B streptococcus (GBS) infection remains a leading cause of sepsis, pneumonia, and meningitis in infants. Rates of GBS early onset disease have declined following the widcespread use of intrapartum antibiotic prophylaxis; hence, late-onset infections (LOGBS) are currently a common presentation of neonatal GBS dicsease. The pathogenesis, mode of transmission, and risk factors associated with LOGBS are unclear, which interfere with effective prevention efforts. GBS may be transmitted from the mother to the infant at the time of delivery or during the postpartum period via contaminated breast milk, or as nosocomial or community-acquired infection. Maternal GBS colonization, prematurity, young maternal age, HIV exposure, and ethnicity (Black) are identified as risk factors for LOGBS disease; however, further studies are necessary to confirm additional risk factors, if any, for the implementation of effective prevention strategies. This narrative review discusses current and previous studies that have reported LOGBS. Few well-designed studies have described this condition; therefore, reliable assessment of maternal GBS colonization, breastfeeding, and twin delivery as risk factors for LOGBS remains limited.

Keywords: CC17; infant; meningitis; neonatal sepsis; prevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Edwards MS, Nizet V, Baker CJ. Group B streptococcal infections. In: Remington and Klein’s Infectious Diseases of the Fetus and Newborn Infant. 8th ed. Elsevier; 2016:411–456.
    1. Dhudasia MB, Flannery DD, Pfeifer MR, Puopolo KM. Updated guidance: prevention and management of perinatal group B Streptococcus infection. Neoreviews. 2021;22(3):e177–e188. doi:10.1542/neo.22-3-e177 - DOI - PubMed
    1. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B Streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR–10):1–36. - PubMed
    1. Di Renzo GC, Melin P, Berardi A, et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med. 2015;28(7):766–782. doi:10.3109/14767058.2014.934804 - DOI - PubMed
    1. Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379(9815):547–556. doi:10.1016/S0140-6736(11)61651-6 - DOI - PubMed

LinkOut - more resources